Chicago Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
5,144
+576
+13% +$50.4K 0.07% 249
2026
Q1
$389K Sell
4,568
-7
-0.2% -$624 0.06% 272
2025
Q4
$362K Buy
4,575
+1,685
+58% +$132K 0.06% 288
2025
Q3
$231K Sell
2,890
-93
-3% -$7.93K 0.03% 376
2025
Q2
$271K Sell
2,983
-1,166
-28% -$106K 0.04% 341
2025
Q1
$389K Sell
4,149
-1,433
-26% -$128K 0.07% 240
2024
Q4
$507K Sell
5,582
-400
-7% -$38.2K 0.09% 203
2024
Q3
$621K Hold
5,982
0.11% 176
2024
Q2
$580K Sell
5,982
-269
-4% -$24.8K 0.12% 155
2024
Q1
$563K Sell
6,251
-1,300
-17% -$110K 0.12% 170
2023
Q4
$602K Hold
7,551
0.13% 157
2023
Q3
$537K Hold
7,551
0.13% 163
2023
Q2
$582K Sell
7,551
-50
-0.7% -$3.87K 0.14% 156
2023
Q1
$571K Sell
7,601
-104
-1% -$7.73K 0.14% 156
2022
Q4
$607K Sell
7,705
-70
-0.9% -$5.25K 0.15% 152
2022
Q3
$546K Sell
7,775
-253
-3% -$19.8K 0.14% 158
2022
Q2
$643K Sell
8,028
-81
-1% -$6.33K 0.16% 142
2022
Q1
$615K Sell
8,109
-750
-8% -$59.4K 0.13% 161
2021
Q4
$756K Buy
8,859
+175
+2% +$13.7K 0.15% 158
2021
Q3
$656K Buy
+8,684
New +$690K 0.14% 165
2019
Q1
Sell
-3,990
Closed -$238 182
2018
Q4
$238 Hold
3,990
0.11% 144
2018
Q3
$268K Buy
+3,990
New +$266K 0.11% 144
2018
Q2
Sell
-4,114
Closed -$295K 169
2018
Q1
$295K Buy
4,114
+810
+25% +$58.3K 0.13% 132
2017
Q4
$249K Buy
3,304
+269
+9% +$19.6K 0.1% 143
2017
Q3
$221 Hold
3,035
0.09% 144
2017
Q2
$225 Hold
3,035
0.1% 139
2017
Q1
$222 Sell
3,035
-1,425
-32% -$99.7K 0.1% 141
2016
Q4
$292K Sell
4,460
-990
-18% -$67.9K 0.13% 124
2016
Q3
$404K Sell
5,450
-378
-6% -$27.9K 0.18% 106
2016
Q2
$426K Sell
5,828
-990
-15% -$70.5K 0.18% 108
2016
Q1
$482K Sell
6,818
-3,824
-36% -$254K 0.2% 104
2015
Q4
$709K Sell
10,642
-1,660
-13% -$110K 0.28% 97
2015
Q3
$781K Sell
12,302
-240
-2% -$15.7K 0.3% 96
2015
Q2
$820K Sell
12,542
-1,100
-8% -$74.6K 0.29% 92
2015
Q1
$946K Buy
+13,642
New +$943K 0.32% 88

Other funds holding CL

Chicago Trust's CL Position: Q2 2026 in Review

Chicago Trust increased its Colgate-Palmolive (CL) stake by 13% in Q2 2026, buying an estimated $50.4K and bringing the position to 5,144 shares worth $472K. The position accounts for 0.07% of the portfolio, ranked #249.

Chicago Trust first reported a position in CL in Q1 2015 and has held it in 35 quarters since. The position peaked at $946K in Q1 2015. 609 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Chicago Trust held 5,144 shares of Colgate-Palmolive worth $472K as of Q2 2026.
  • Chicago Trust bought 576 Colgate-Palmolive shares in Q2 2026, an estimated $50.4K.
  • Colgate-Palmolive made up 0.07% of Chicago Trust's portfolio in Q2 2026, its #249 holding.
  • Chicago Trust first reported a position in Colgate-Palmolive in Q1 2015 and has held it in 35 quarters since.
  • Chicago Trust's Colgate-Palmolive position peaked at $946K in Q1 2015.
  • 609 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.